UNSPSC 51271625: Butanilicaine phosphate

This classification denotes an anesthetic agent with the molecular formula C13H19CLN2O.H3O4P, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier JOZ20TRV0N. European Medicines Agency schedules butanilicaine phosphate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00912MIG. The term butanilicaine phosphate is a U.S. FDA designation. Most nations, for tariff and trade purposes, schedule butanilicaine phosphate under HS 29242995 and SITC 51479.

As of Q4 2014, BUTANILICAINE PHOSPHATE remains US FDA's Preferred Term for this commodity. Butanilicaine phosphate bears US NLM identifiers UMLS ID C0888854 and NCI Concept Code C97305. SMILES: CCCCNCC(=O)NC1C(CCCC1CL)C.OP(=O)(O)O.

UNSPSC 51271625 Butanilicaine phosphate, a Commodity code, covers local anesthetic pharmaceutical products used in medical and dental procedures across state and local health systems. State and local governments procure this active pharmaceutical ingredient and finished formulations through health departments, public health agencies, correctional health systems, and municipal clinics that maintain anesthesia stocks for routine surgical, dental, and emergency procedures. The product sees use in outpatient surgery centers, emergency departments, and correctional medical facilities operated by counties and states.

The source provides no recent state or local contract opportunities tagged to this code. Without posted solicitations, current market activity, geographic concentration, or issuing-body patterns cannot be characterized.